IntelliCyt Launches iQue Screener for Multiplexed Screening of Suspension Assays

11 Jul 2013
Sarah Thomas
Associate Editor

Product news

IntelliCyt Corporation, a provider of assay screening solutions for phenotypic drug discovery, antibody discovery and in vitro toxicity testing, recently announced the commercial launch of their new iQue™ Screener. The system is the latest addition to IntelliCyt’s platform of instrumentation, application-specific reagents, integrated multi-user analysis and informatics tools.

IntelliCyt also announced it has obtained the CE Mark for the iQue Screener clearing the company to sell it in the European Union and other countries recognizing the CE Mark. The company also announced that it has opened an office in California to support its growing commercial operations.

“Reception to the iQue Screener since our introduction at the Society for Laboratory Automation and Screening (SLAS) in January has been very positive,” commented Terry Dunlay, CEO at IntelliCyt. “Our early access customers have praised the system, which has enabled them to drastically reduce time to final result and cost for critical assays.”

“As part of our growth, we have opened an office in Los Altos, California for our expanding sales, marketing and business development functions,” Dunlay continued. “In addition to supporting our growth globally, the office is located close to the important Bay Area and San Diego biotechnology markets.”

IntelliCyt’s iQue system is the first high-throughput, high-content fully integrated analyzer designed for rapid screening of cells and beads in suspension. Unlike other screening technologies that provide data on a per well basis, IntelliCyt’s technology provides information-rich data on a cell-by-cell basis in 96- and 384-well microplates. The system’s micro-volume sample delivery with rapid sample processing, application-specific MultiCyt™ reagent kits, and easy-to-use yet powerful ForeCyt® Software is a comprehensive solution for researchers who need highly sensitive multiplexing capabilities to screen large libraries at unprecedented speed and also drastically reduce costs.

Links

Tags

AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.High-Throughput ScreeningHigh-throughput screening (HTS) is an automated drug discovery technique for identification of active compounds against a compound library. Use HTS readers and integrated assay preparation / analysis workstations to screen your compounds. Identify active compounds against various HTS libraries, including membranes, proteins and peptides and HTS cell lines. Find the best high-throughput screening products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Chem / BioinformaticsCheminformatics and bioinformatics are computational techniques used in chemistry and biology, respectively, for data acquisition, processing and storage. Cheminformatics focuses on compound information, whereas bioinformatics is mainly applied to analysis and modeling of genomics, genetic and sequencing information. Hardware and software is available for data acquisition, analysis, management and storage.Cell-Based AssaysCell-based assays are used to monitor the presence, quantity and activities of a desired cellular analyte including drug molecules or biomarkers. This can reveal information on cell health (apoptosis, cytotoxicity, viability and proliferation assays), cell metabolism, cell migration and cell signaling mechanisms. Find the best cell-based assay products, kits and equipment with our peer reviewed product directory: compare products, check customer reviews and receiving pricing direct from manufacturers.ToxicityToxicity is defined as the degree to which a substance can harm humans or animals. It is essential to study the toxicity of pharmaceutical products during the development process so that optimum dosage can be established for the administration of the drug.MultiplexingMultiplexing refers to the ability to measure multiple targets or analytes simultaneously in a single experiment. This technique is valuable for high-throughput screening, diagnostics, and complex assays, as it increases efficiency and data quality. Browse our peer-reviewed product directory to find the best multiplexing products, compare tools, check reviews, and get pricing directly from manufacturers.
IntelliCyt Launches iQue Screener for Multiplexed Screening of Suspension Assays